Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs

Omar A. Saldarriaga, Bruno Travi, Won Park, Luis E. Perez, Peter Melby

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Vaccination of dogs, the domestic reservoir of Leishmania chagasi, could not only decrease the burden of canine visceral leishmaniasis (VL), but could also indirectly reduce the incidence of human VL. Intramuscular vaccination of foxhounds with a Leishmania multicomponent (10 antigen) DNA vaccine resulted in antigen-induced lymphoproliferative and IFN-γ (but not IL-4) responses. This response was not augmented by co-administration of canine IL-12 or GM-CSF DNA adjuvants. The multicomponent DNA vaccine also induced a delayed type hypersensitivity (DTH) response to viable L. donovani promastigotes and led to a reduction of parasite burden in an in vitro intracellular infection model, and in the draining lymph node of dogs early after cutaneous challenge. Thus, the multicomponent DNA vaccine was effective in priming dogs for a parasite-specific type 1 cellular immune response, which was able to restrict parasite growth.

Original languageEnglish
Pages (from-to)1928-1940
Number of pages13
JournalVaccine
Volume24
Issue number11
DOIs
StatePublished - Mar 10 2006
Externally publishedYes

Fingerprint

DNA Vaccines
visceral leishmaniasis
Visceral Leishmaniasis
recombinant vaccines
Parasites
immune response
Dogs
Canidae
dogs
Vaccination
Leishmania infantum
Antigens
parasites
Leishmania
Delayed Hypersensitivity
Interleukin-12
Granulocyte-Macrophage Colony-Stimulating Factor
Cellular Immunity
Interleukin-4
vaccination

Keywords

  • Cellular immunity
  • Interferon-gamma
  • Leishmania chagasi
  • Leishmania donovani
  • Vaccine
  • Visceral leishmaniasis

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs. / Saldarriaga, Omar A.; Travi, Bruno; Park, Won; Perez, Luis E.; Melby, Peter.

In: Vaccine, Vol. 24, No. 11, 10.03.2006, p. 1928-1940.

Research output: Contribution to journalArticle

Saldarriaga, Omar A. ; Travi, Bruno ; Park, Won ; Perez, Luis E. ; Melby, Peter. / Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs. In: Vaccine. 2006 ; Vol. 24, No. 11. pp. 1928-1940.
@article{1ce21d4344b740b9a5f411ad299eb7a6,
title = "Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs",
abstract = "Vaccination of dogs, the domestic reservoir of Leishmania chagasi, could not only decrease the burden of canine visceral leishmaniasis (VL), but could also indirectly reduce the incidence of human VL. Intramuscular vaccination of foxhounds with a Leishmania multicomponent (10 antigen) DNA vaccine resulted in antigen-induced lymphoproliferative and IFN-γ (but not IL-4) responses. This response was not augmented by co-administration of canine IL-12 or GM-CSF DNA adjuvants. The multicomponent DNA vaccine also induced a delayed type hypersensitivity (DTH) response to viable L. donovani promastigotes and led to a reduction of parasite burden in an in vitro intracellular infection model, and in the draining lymph node of dogs early after cutaneous challenge. Thus, the multicomponent DNA vaccine was effective in priming dogs for a parasite-specific type 1 cellular immune response, which was able to restrict parasite growth.",
keywords = "Cellular immunity, Interferon-gamma, Leishmania chagasi, Leishmania donovani, Vaccine, Visceral leishmaniasis",
author = "Saldarriaga, {Omar A.} and Bruno Travi and Won Park and Perez, {Luis E.} and Peter Melby",
year = "2006",
month = "3",
day = "10",
doi = "10.1016/j.vaccine.2005.10.052",
language = "English",
volume = "24",
pages = "1928--1940",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs

AU - Saldarriaga, Omar A.

AU - Travi, Bruno

AU - Park, Won

AU - Perez, Luis E.

AU - Melby, Peter

PY - 2006/3/10

Y1 - 2006/3/10

N2 - Vaccination of dogs, the domestic reservoir of Leishmania chagasi, could not only decrease the burden of canine visceral leishmaniasis (VL), but could also indirectly reduce the incidence of human VL. Intramuscular vaccination of foxhounds with a Leishmania multicomponent (10 antigen) DNA vaccine resulted in antigen-induced lymphoproliferative and IFN-γ (but not IL-4) responses. This response was not augmented by co-administration of canine IL-12 or GM-CSF DNA adjuvants. The multicomponent DNA vaccine also induced a delayed type hypersensitivity (DTH) response to viable L. donovani promastigotes and led to a reduction of parasite burden in an in vitro intracellular infection model, and in the draining lymph node of dogs early after cutaneous challenge. Thus, the multicomponent DNA vaccine was effective in priming dogs for a parasite-specific type 1 cellular immune response, which was able to restrict parasite growth.

AB - Vaccination of dogs, the domestic reservoir of Leishmania chagasi, could not only decrease the burden of canine visceral leishmaniasis (VL), but could also indirectly reduce the incidence of human VL. Intramuscular vaccination of foxhounds with a Leishmania multicomponent (10 antigen) DNA vaccine resulted in antigen-induced lymphoproliferative and IFN-γ (but not IL-4) responses. This response was not augmented by co-administration of canine IL-12 or GM-CSF DNA adjuvants. The multicomponent DNA vaccine also induced a delayed type hypersensitivity (DTH) response to viable L. donovani promastigotes and led to a reduction of parasite burden in an in vitro intracellular infection model, and in the draining lymph node of dogs early after cutaneous challenge. Thus, the multicomponent DNA vaccine was effective in priming dogs for a parasite-specific type 1 cellular immune response, which was able to restrict parasite growth.

KW - Cellular immunity

KW - Interferon-gamma

KW - Leishmania chagasi

KW - Leishmania donovani

KW - Vaccine

KW - Visceral leishmaniasis

UR - http://www.scopus.com/inward/record.url?scp=32544450112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32544450112&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.10.052

DO - 10.1016/j.vaccine.2005.10.052

M3 - Article

C2 - 16310897

AN - SCOPUS:32544450112

VL - 24

SP - 1928

EP - 1940

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 11

ER -